Risiko und Prophylaxe thromboembolischer Komplikationen bei gynäkologischen Malignomen

Gynakologisch-geburtshilfliche Rundschau

Volumn 36, Issue 1, 1996, Pages 37-49

  Graf, A H ^a   Graf, B ^b   Traun, H ^b   Staudach, A ^a  

^a Salzburger Landeskliniken   (Austria)

^b Hämoslasiologie der II Medizinischen Abteilung   (Austria)

Author keywords

Gynecologic oncology; Thromboembolic complications; Thromboembolism prophylaxis

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; LUNG EMBOLISM; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; THROMBOPHLEBITIS; TREATMENT OUTCOME; UTERUS CANCER;

ACENOCOUMAROL; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FEMALE; GENITAL NEOPLASMS, FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; THROMBOPHLEBITIS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0029693915     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000272610     Document Type: Article

References (14)

1. Clark-Pearson DL, Olt G: Thromboembolism in patients with gynecologic tumors: Risk factors, natural history and prophylaxis., Oncology 1989;3:39-45.
2. Prandoni P, Lensing AW, Biiller HR, Cogo A, Prins MA, Cattelan AM, Luppini S, Noventa R, ten Cate JW: Deep-vein thrombosis and the incidence of subsequent symptomatic cancer., N Engl J Med 1992;327:1128-1133.
3. Monreal M, Casals A, Boix J, Olazabal A, Montserrat E, Mundo MR: Occult cancer in patients with acute pulmonary embolism: A prospective study., Chest 1993; 103:816-819.
4. Graf A-H, Graf B., Riedl B, Traun H, Staudach A: Risiko und Prophylaxe thromboemboli-scher Komplikationen beim Zervix- und Korpuskarzinom., Gynäkol Geburtshilfliche Rundsch 1994;34(Suppl 1):95-96.
5. Walsh JJ, Bonnar J, Wright FW: A study of pulmonary embolism and deep leg vein thrombosis after major gynecologic surgery using labeled Fibrinogen, phlebography and lung scanning., J Obstet Gynaecol Br Commonwealth 1974;31:311-316.
6. Heidegger H., von Hugo R, Graeff H: Thromboembolism in gynecologic oncology., Eur J Gynaecol Oncol 1991;12:341-345.
7. Clarke-Pearson DL, Jelovsek FR, Creasman WT: Thromboembolism complicating surgery for cervical and uterine malignancy: Incidence, risk factors and prophylaxis., Obstet Gynecol 1983;61:87-94.
8. Goemer A: The influence of anticloning agents on transplantation and growth of tumor tissue., J Lab Clin Med 1930;16:369-372.
9. Wood S: Pathogenesis of metastasis formation in vivo in the rabbit ear., Arch Pathol 1958:66: 440.
10. Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D., Goodwin P: Double-blind randomized trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer., Lancet 1994;343:886-889.
11. Zacharski LR: Anticoagulation in the treatment of cancer in man; in Donati MB, Davidson R (Hrsg): Malignancy and the Hemostatic System., New York, Raven Press, 1981., pp 113-127.
12. Zacharski LR: Small cell carcinoma of the lung: Interaction with the blood coagulation mechanism and treatment with anticoagulants., Oncology 1987;10:264-270.
13. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Mcmoli VA: Pathways of coagulation/fibrinolysis activation in malignancy., Semin Thromb Hemost 1992; 18:104-116.
14. Zacharski LR, Memoli VA, Ornstein DL, Rousseau SM, Kisiel W, Kudryk BJ: Tumor cell procoagulant and urokinase expression in carcinoma of the ovary., J Natl Cancer Inst 1993:85:1225-1230.